Tuberculosis news from FierceBiotech
NewsGlobal demographic trends threaten drug industry
You can file the following under the category of really, really bleak forecasts: The rising cost of healthcare in the developing world matched by an aging population is creating a perfect storm for Read more...
Biotech nonprofit to make meds with donated IP
The Connecticut biotech group CURE has set up a nonprofit subsidiary and staffed it with a couple of experienced R&D specialists out to turn the drug development world's cast-offs into low-cost Read more...
| Press ReleasesPRESS RELEASE: New Antibiotic Drug Combo To Speed Up Treatment of Tuberculosis New Antibiotic Drug Combo To Speed Up Treatment of Tuberculosis (Scheduled for presentation at 8:30 a.m. CDT/9:30 a.m. EDT, Tuesday, Sept. 18; oral presentation #L-736A, Room E450B, McCormick Place Read more... |
Get more Tuberculosis coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets